Correction to: A double-blind, placebo-controlled, randomized trial of PXT3003 for the treatment of Charcot–Marie–Tooth type 1A
Shahram Attarian, Peter Young, Thomas H. Brannagan, David Adams, Philip Van Damme, Florian P. Thomas, Carlos Casanovas, Jafar Kafaie, Céline Tard, Maggie C. Walter, Yann Péréon, David Walk, Amro Stino, Marianne de Visser, Camiel Verhamme, Anthony Amato, Gregory Carter
Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsHereditary Neurological Disorders
Correction to: Orphanet Journal of Rare Diseases (2021) 16:433
10.1186/s13023-021-02040-8
Following publication of the original article [1], we have been notified that we should add one more author to the authors’ group:
Jafar Kafaie 8
8 Department of Neurology, Saint Louis University School of Medicine, St. Louis, USA
The original article was updated.
The reference list from the paper itself. Each links out to its DOI / PubMed record.